Spermosens AB (SPERM.ST)

SEK 0.01

(7.69%)

Operating Expenses Summary of Spermosens AB

  • Spermosens AB's latest annual operating expenses in 2023 was 10.72 Million SEK , down -19.0% from previous year.
  • Spermosens AB's latest quarterly operating expenses in 2024 Q1 was 2.64 Million SEK , up 72.68% from previous quarter.
  • Spermosens AB reported a annual operating expenses of 13.24 Million SEK in annual operating expenses 2022, up 35.44% from previous year.
  • Spermosens AB reported a annual operating expenses of 9.77 Million SEK in annual operating expenses 2021, up 242.78% from previous year.
  • Spermosens AB reported a quarterly operating expenses of 2.04 Million SEK for 2024 Q2, down -22.41% from previous quarter.
  • Spermosens AB reported a quarterly operating expenses of 2.11 Million SEK for 2024 Q3, up 2.93% from previous quarter.

Annual Operating Expenses Chart of Spermosens AB (2023 - 2020)

Historical Annual Operating Expenses of Spermosens AB (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 10.72 Million SEK -19.0%
2022 13.24 Million SEK 35.44%
2021 9.77 Million SEK 242.78%
2020 2.85 Million SEK 0.0%

Peer Operating Expenses Comparison of Spermosens AB

Name Operating Expenses Operating Expenses Difference
AroCell AB (publ) 57.68 Million SEK 81.407%
Devyser Diagnostics AB (publ) 204.6 Million SEK 94.758%
Immunovia AB (publ) 291.35 Million SEK 96.319%
Prostatype Genomics AB (publ) 3.22 Million SEK -232.558%
SenzaGen AB 49.67 Million SEK 78.408%